IP Library Granted Patent US 9,095,524
Granted Patent B2
US 9,095,524 · App. 13/649,620 · Granted Aug 4, 2015

Customized compositions and uses thereof

Inventors: Patrick Warnke (Robina, AU); Qin Liu (Queensland, AU)
Assignee: Bond University LTD
A61K9/7007A61L27/14A61L27/3834A61L27/56A61L27/60A61L2400/12A61L2430/16B82Y5/00Y10S977/788
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,524
App. No.
13/649,620
Granted
Aug 4, 2015
Kind
B2
Abstract

The present invention relates to a customized composition comprising three-dimensional (3D) nanofiber webbing. The present invention further relates to the process of producing the composition comprising 3D nanofiber webbing and uses thereof such as treatment of age-related macular degeneration or regeneration/repair of tissue.

Claims (18)

1. A composition to treat age-related macular degeneration or other retinal diseases or disorders, wherein the composition comprises a three-dimensional (3D) membrane comprising electrospun nanofibers made by at least one polymer, the at least one polymer comprising PLGA, PCL, elastin, collagen or combinations thereof, wherein the membrane is ultrathin and comprises a packing density and fiber diameter sufficient to load stem cell derived retinal cells onto the membrane, the membrane further comprising a protein coat between the nanofibers and the stem cell derived retinal cells, wherein the thickness of the membrane is between about 2 microns to about 20 microns and the packing density is between about 15% to about 70% and the fiber diameter is between about 250 nm to about 670 nm.

2. The composition of claim 1 , wherein the packing density and fiber diameter of the membrane allow the loaded stem cell derived retinal cells to proliferate into a functional monolayer of retinal pigment epithelium.

3. The composition of claim 2 , wherein the retinal pigment epithelium treats age-related macular degeneration or other retinal diseases or disorders.

4. The composition of claim 1 , wherein the topography and modulus of the membrane resembles the topography and modulus of native human Bruch's membrane.

5. The composition of claim 1 , further comprising photoreceptor cells.

6. The composition of claim 5 , wherein the photoreceptor cells and retinal pigment epithelial cells make up a bilayer, said retinal pigment epithelial cells facing the membrane.

7. The composition of claim 1 , wherein the composition is flexible and is therefore contoured to the shape of the implant site by surrounding tissue.

8. The composition of claim 1 , wherein the two or more polymers are natural and/or synthetic and biodegradable.

9. A composition comprising a protein-coated nanofiber membrane supporting a functional monolayer of stem cell derived retinal pigment epithelial cells, wherein the composition is obtainable by a process comprising the following steps:

(a) placing a collector in an electric field of a nanofiber electrospinning machine;

(b) dispersing one or more polymers through an electric field to contact the collector for a time and under conditions sufficient to produce packing density and nanofiber diameter of the membrane to resemble the topography of native human Bruch's membrane, and a thickness of the membrane to support cell growth and mimic the mechanical properties of native human Bruch's membrane;

(c) removing the membrane from the collector;

(d) washing and sterilizing the membrane;

(e) coating the membrane with a protein coat;

(f) loading the membrane with stem cell derived retinal cells; and

(g) culturing the cells in vitro to functional maturity.

10. The composition of claim 9 , wherein photoreceptor cells are loaded onto the retinal pigment epithelial cell-loaded membrane.

11. The composition of claim 1 or 6 , wherein the composition is implanted subretinally into a patient's eye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2014
From: LIU, QIN
To: BOND UNIVERSITY LTD
Reel/Frame 033169/0793 →
Priority Claims (1)
AU 2011904165 · Oct 11, 2011 · national
Continuity (1)
Related Publication 20130095167A1 · Apr 18, 2013